Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_078cb8366425c7f7bb46338421d23406 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 |
filingDate |
2013-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28b3f92b5a1ad2eef799c8bdbf54abc9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b0ed8688b1febdee564700ded77b48e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e069914601b8151de5f0eb58911f6a7c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f069ef1dda16d3fda05e711a8682909 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf318d3090d6ffdbbdc46e067c8ca671 |
publicationDate |
2014-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-103232443-B |
titleOfInvention |
Indazole derivative crystal and its preparation method and use |
abstract |
The invention relates to an indazole derivative crystal and its preparation method and use. The indazole derivative crystal is a pazopanib hydrochloride crystal L. The invention comprises a pharmaceutical composition of the pazopanib hydrochloride crystal L and a use thereof. The pazopanib hydrochloride crystal L is characterized by an X-powder diffraction pattern and an infrared spectrogram. |
priorityDate |
2013-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |